Amendment H-8050 to HF 2492
Relating to insurance coverage for biomarker testing
Never voted on
Filed February 26, 2024 in the House by
What it changes
- Page 1, after line 7 by inserting: “___. Page 2, by striking lines 16 and 17 and inserting “testing has demonstrated clinical utility, or when the biomarker testing is considered to be a medically necessary service for coverage pursuant to subsection 5, paragraph “b” , provided that biomarker test results that provide information that is used in the formulation of a treatment or monitoring strategy that informs a covered person’s outcome and impacts the clinical decision shall be considered medically necessary services pursuant to subsection 5, paragraph “b” , including but not limited to any of the following:””
- By renumbering as necessary.